Affiliation:
1. Hamamatsu University School of Medicine
2. St. Mary’s Hospital
3. JA Hiroshima Hospital
Abstract
Abstract
Background: Fentanyl is selected to manage pain in critical care patients in the intensive care unit (ICU). However, the usefulness of fentanyl has not been established. This study examined the evidence for the use of fentanyl to improve the clinical outcomes in ICU patients, using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.Methods: We searched the MEDLINE, Cochrane Central Register of Controlled Trials, and Igaku Chuo Zasshi databases in June 2021. Two independent assessors reviewed studies to identify randomized, controlled trials that compared the intravenous administration of fentanyl and other opioids in mechanically ventilated patients. The study quality was assessed using the GRADE system and Cochrane methodology. The primary outcome was mortality. Secondary outcomes were the duration of mechanical ventilation, duration of the ICU stay, incidence of severe adverse events, and incidence of delirium. We integrated outcome data using a random-effects model and showed absolute values and certainty of evidence in the GRADE evidence profile.Results: Eleven Randomized Controlled Trials met the study inclusion criteria with 1312 patients (643 were treated with fentanyl and 669 with other opioids, including 628 with remifentanil and 41 with morphine). Among 816 participants from 4 RCTs, fentanyl was not associated with mortality (risk ratio [RR], 0.74; 95% confidence interval [CI], 0.28 to 2.00; low-quality evidence). Regarding the secondary outcomes, fentanyl did not shorten the duration of mechanical ventilation (mean difference [MD], −1.71 h; 95% CI, −3.79 to 0.37; moderate-quality evidence) or the duration of the ICU stay (MD, −1.89 h; 95% CI, −5.00 to 1.22; moderate-quality evidence) compared with other opioids. Fentanyl also did not increase the incidence of severe adverse events (RR, 0.80; 95% CI, 0.56 to 1.15; moderate-quality evidence) or delirium (RR, 1.27; 95% CI, 0.79 to 2.04; low-quality evidence). Conclusions: Although fentanyl is a frequently administered opioid in ICUs worldwide, the current analysis found no evidence to support its clinical use. However, the GRADE evaluation provides little certainty to support the results of this systematic review, and further large RCTs are therefore needed to confirm the conclusions.Trial registration: PROSPERO, CRD42019130648https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=130648
Publisher
Research Square Platform LLC
Reference36 articles.
1. Posttraumatic stress, anxiety and depression symptoms in patients during the first year post intensive care unit discharge;Myhren H;Crit Care,2010
2. Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40:502–9.
3. Exploring the scope of post-intensive care syndrome therapy and care: engagement of non-critical care providers and survivors in a second stakeholders meeting;Elliott D;Crit Care Med,2014
4. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU;Devlin JW;Crit Care Med,2018
5. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit;Barr J;Crit Care Med,2013